Stock Ratings | Barclays raises Snap target to $16 (potential upside 176.34%); Rosenblatt recommends buying SK Hynix with a target of $320

Snap
Ameresco, Inc. Class A
Bitdeer Technologies
SK hynix Inc. Sponsored ADR
FibroBiologics, Inc.

Snap

SNAP

0.00

Ameresco, Inc. Class A

AMRC

0.00

Bitdeer Technologies

BTDR

0.00

SK hynix Inc. Sponsored ADR

SKHY

0.00

FibroBiologics, Inc.

FBLG

0.00

The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

Barclays: Maintaining an "overweight" rating on Snap Snap(SNAP.US) ) stock, while raising its price target from $15 to $16.

Canaccord Genuity: Maintaining a "buy" rating on Ameresco ( Ameresco, Inc. Class A(AMRC.US) ), while raising the price target from $59 to $62.

Needham: Maintaining a "buy" rating on Bitdeer Techs ( Bitdeer Technologies(BTDR.US) ), while raising the price target from $19 to $22.

Rosenblatt: Initial rating for SK Hynix ( SK hynix Inc. Sponsored ADR(SKHY.US) ) at "Buy", with a target price of $320.

HC Wainwright & Co.: Maintaining a "buy" rating on FibroBiologics ( FibroBiologics, Inc.(FBLG.US) ), while lowering the price target from $8 to $6.

The symbol Classification Target price Current price Percentage of potential increase/decrease (Classification) Agency
Snap(SNAP.US) to lift $16.0 $5.79 176.34% Barclays
Ameresco, Inc. Class A(AMRC.US) to lift $62.0 $27.94 121.9% Canaccord Genuity
Bitdeer Technologies(BTDR.US) to lift $22.0 $11.38 93.32% Needham
Ultra Clean Holdings, Inc.(UCTT.US) to lift $150.0 $84.54 77.43% Oppenheimer
Amer Sports, Inc.(AS.US) to lift $64.0 $36.22 76.7% JP Morgan
SK hynix Inc. Sponsored ADR(SKHY.US) Initial classification $320.0 $154.38 107.28% Rosenblatt
FibroBiologics, Inc.(FBLG.US) cut $6.0 $0.822 629.93% HC Wainwright & Co.
Wave Life Sciences Ltd.(WVE.US) cut $23.0 $6.0 283.33% Mizuho
5E Advanced Materials, Inc.(FEAM.US) cut $3.5 $1.32 165.15% HC Wainwright & Co.
Alnylam Pharmaceuticals, Inc(ALNY.US) cut $455.0 $219.0 107.76% HC Wainwright & Co.

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

Canaccord Genuity: Maintaining a "buy" rating on Datadog ( Datadog(DDOG.US) ) stock, while raising the price target from $250 to $295.

DA Davidson: Maintaining a "buy" rating on Palantir Technologies Palantir(PLTR.US) ), raising the price target from $175 to $200.

Citigroup: Maintaining a "buy" rating on Palantir Technologies Palantir(PLTR.US) , raising its price target from $200 to $245.

UBS: Maintaining a "neutral" rating on Snap Snap(SNAP.US) ) stock, while raising its price target from $5 to $5.7.

Citigroup: Maintaining a "neutral" rating on Snap Snap(SNAP.US) ) stock, while raising its price target from $6.5 to $6.75.

First Coverage

DA Davidson: Initial rating for SailPoint ( SailPoint, Inc.(SAIL.US) ) stock at "neutral", with a price target of $17.

Cantor Fitzgerald: Initial rating for SK Hynix ( SK hynix Inc. Sponsored ADR(SKHY.US) ) at "overweight", with a price target of $300.

Needham: Initial rating for Vishay Intertechnology ( Vishay Intertechnology, Inc.(VSH.US) ) stock at "Buy", with a target price of $45.

reduction

JP Morgan: Downgraded Nike ( NIKE, Inc. Class B(NKE.US) ) to "Underweight," with a price target cut from $47 to $40.

Truist Securities: Maintaining a "Hold" rating on Snap Snap(SNAP.US) ) stock, while lowering the price target from $8 to $7.

Mizuho: Maintaining its "Outperform Market" rating for Wave Life Sciences ( Wave Life Sciences Ltd.(WVE.US) ), while lowering its price target from $27 to $23.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.